Home › Prostate Cancer › Maryland › Baltimore
Prostate Cancer clinical trials in Baltimore, MD
45 studies for Prostate Cancer are looking for participants at sites in and around Baltimore (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
RecruitingPhase 3
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
RecruitingPhase 2
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Recruiting
- Anne Arundel Urology, Annapolis · 22 mi away
WATER IV PCa (AS Sub-study)
Recruiting
- Johns Hopkins University, Baltimore
Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe
RecruitingPhase 1
- Johns Hopkins Hospital, Baltimore
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
RecruitingPhase 2
- University of Maryland Greenebaum Cancer Center, Baltimore
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- and 2 more
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
RecruitingPhase 3
- Maryland Proton Treatment Center, Baltimore
- University of Maryland/Greenebaum Cancer Center, Baltimore
- UM Baltimore Washington Medical Center/Tate Cancer Center, Glen Burnie · 9 mi away
- and 1 more
The COSMYC Trial (COmbined Suppression of MYC)
RecruitingPhase 2
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
RecruitingPhase 3
- Greenebaum Comprehensive Cancer Center ( Site 0021), Baltimore
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
RecruitingPhase 1
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
Exercise in Prostate Cancer
Recruiting
- Johns Hopkins University, Baltimore
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 2
- Johns Hopkins University, Baltimore
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RecruitingPhase 3
- Maryland Proton Treatment Center, Baltimore
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Veterans Administration Medical Center-Baltimore, Baltimore
- and 4 more
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
RecruitingObservational study
- Johns Hopkins University, Baltimore
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
RecruitingPhase 3
- Baltimore Veterans Affairs Medical Center ( Site 0069), Baltimore
- Greenebaum Comprehensive Cancer Center ( Site 0049), Baltimore
- Chesapeake Urology ( Site 0009), Towson · 8 mi away
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
RecruitingPhase 3
- University of Maryland Greenebaum Cancer Center, Baltimore
- Johns Hopkins Hospital Sidney Kimmell Comprehensive Cancer Center, Baltimore
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
RecruitingPhase 3
- Research Site, Baltimore
- Research Site, Baltimore
- Research Site, Towson · 8 mi away
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
RecruitingPhase 3
- Johns Hopkins Hospital, Baltimore
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
RecruitingPhase 3
- Research Site, Towson · 8 mi away
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center, Baltimore
Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
RecruitingObservational study
- Chesapeake Urology Associates, Towson · 8 mi away
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
RecruitingPhase 1
- University of Maryland, Greenebaum Comprehensive Cancer Center, Baltimore
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
RecruitingPhase 2
- Chesapeake Urology Research Associates, Towson · 8 mi away
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
RecruitingObservational study
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
Recruiting
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Transrectal Ultrasound Robot-Assisted Prostate Biopsy
Recruiting
- Johns Hopkins Hospital, Baltimore
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
RecruitingPhase 1/2
- Johns Hopkins Hospital, Baltimore
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RecruitingPhase 3
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
RecruitingPhase 1
- Marlene & Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore
7-Days Water-Only Fasting or Ketone Supplementation Trial in Prostate Cancer
Recruiting
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
RecruitingPhase 1
- Advanced Molecular Imaging and Therapy, Glen Burnie · 9 mi away
- United Theranostics - Chesapeake, Glen Burnie · 9 mi away
TERPS Trial for de Novo Oligometastic Prostate Cancer
RecruitingPhase 2
- Maryland Proton Treatment Center, Baltimore
- UMMC, Baltimore
- Baltimore Washington Medical Center, Glen Burnie · 9 mi away
- and 1 more
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
RecruitingObservational study
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Clinical Trial of Approaches to Prostate Cancer Surgery
Recruiting
- Johns Hopkins University, Baltimore
SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization
RecruitingObservational study
- Johns Hopkins University, Baltimore
Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
RecruitingPhase 2
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer
RecruitingPhase 2
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT
RecruitingEarly phase 1
- SKCCC at Johns Hopkins, Baltimore
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RecruitingPhase 1
- Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
RecruitingPhase 1
- Chesapeake Urology, Towson · 8 mi away
Physician- and Patient-based Barriers to NGS Testing
Recruiting
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
RecruitingPhase 2
- Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · 8 mi away
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
RecruitingPhase 1/2
- Johns Hopkins, Baltimore
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY101 studies
- Houston, TX73 studies
- Los Angeles, CA64 studies
- Boston, MA56 studies
- Seattle, WA45 studies
- St. Louis, MO45 studies
- Chicago, IL45 studies
- San Francisco, CA44 studies
- Philadelphia, PA41 studies
- Nashville, TN40 studies
- Washington, DC39 studies
- Dallas, TX39 studies
Other studies in Baltimore
- Non-Small Cell Lung Cancer60 studies
- Breast Cancer44 studies
- Lung Cancer41 studies
- Cancer (all types)36 studies
- Colorectal Cancer30 studies
- Pancreatic Cancer30 studies
- Metastatic Cancer26 studies
- Obesity24 studies
- Bladder Cancer24 studies
- Ovarian Cancer23 studies
- Heart Failure23 studies
- Stroke20 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.